China Blood Products Industry Report, 2007-2008
  • Dec/2008
  • Hard Copy
  • USD $950 $665
  • Pages:30
  • Single User License
    (PDF Unprintable)       
  • USD $950 $665
  • Code: FA008
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $1,450 $1,015
  • Hard Copy + Single User License
  • USD $1,150 $805
      

China blood products industry is all along comparatively independent from global blood products industry. In the year of 1986, according to the rules from Ministry of Health, China prohibited the import of blood products except HAS. However, since 2002, HAS import had been also prohibited from BSE disease regions.

Considering the short supply of domestic blood products, in May 2008, State Council of China adjusted the import tariff of HSA products from 3% to zero during 1st Jun 2008 to the end of Dec 2008. However, due to the HAS price in China market lower than international market, foreign companies are seldom willing to export.

China has totally 33 blood products manufacturers. In the year of 2007, the blood products market scale in China was about CNY 6 billion. China has a great demand for albumin, due to the large number of liver disease patients; the other blood products also have a considerable demand in China such as gammaglobulin, immunoglobulin and plasma thromboplastin component.


Market Structure of China Blood Products, 2007

blood.jpg

Source: ResearchInChina

Based on the authoritative statistics from General Administration of China Customs, Pharmaceutical Industry Association and National Bureau of Statistics, this report is focused on the actuality of China blood products industry, as well as its development trend and investment opportunities and risks.

 

1. Overview of China Blood Products Industry
1.1 Market Overview
1.2 Key Manufacturers 

2. China Blood Plasma Market
2.1 Blood Plasma Stations
2.2 Blood Plasma Production
2.3 Blood Plasma Price

3. Development of Global Blood Products Industry
3.1 Development Courses
3.2 Status Quo

4. Key Blood Products
4.1 HSA
4.2 IVIG
4.3 HBIG
4.4 Rabies Immunoglobulin
4.5 Tetanus Immunoglobulin
4.6 PTC

5. Key Manufacturers in China 
5.1 Overview
5.2 Hualan Biological Engineering Co., Ltd
5.3 Shanghai RAAS Blood Products Co., Ltd
5.4 Shanghai Institute of Biological Products
5.5 Chengdu Rongsheng Pharmaceuticals Co., Ltd
5.6 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd
5.7 Guiyang Qianfeng Biological Product Liability Co., Ltd.

6. Investment Analysis 
6.1 Opportunities 
6.2 Risks
6.3 Suggestions
Market Structure of China Blood Products, 2007
Regional Sales of Top Six Blood Products Manufacturers in China, 2007
China Blood Products Industry Chain After the Reform of Blood Plasma Stations
Key Regulations of Blood Products in China
China Blood Plasma Productions, 2001-2007
China Blood Plasma Price and Forecast, 2005-2010
Blood Plasma Collection of Key Global Blood Products Manufacturers, 2007
Market Share Distribution of Global Key Blood Products Manufacturers, 2007
HAS Market Share Distribution of Hospitals in China, 2007
HAS Price Trend in China 
China and Global HAS Consumption Per Capital 
Sales Revenue of PTC in 16 Cities in China, 2001-2006
Major Products of Top Six Blood Products Manufacturers in China, 2007
Sales Revenue and Forecast of Hualan Biological Engineering Co., Ltd., 2007-2010
Profitability of Hualan Biological Engineering Co., Ltd &Shanghai RAAS Blood Products Co., Ltd
Major Products of Shanghai RAAS Blood Products Co., Ltd
Blood Plasma Collection and Production of Shanghai RAAS Blood Products Co., Ltd., 2005-2010
Sales Revenue and Forecast of Shanghai RAAS Blood Products Co., Ltd., 2005-2010
Fund-raising Investment Projects of of Shanghai RAAS Blood Products Co., Ltd., 2008
Blood Products of Shanghai Institute of Biological Products
Sales Network of Shanghai Institute of Biological Products, 2007
Sales Revenue, Net Profit and Forecast of Chengdu Rongsheng Pharmaceuticals Co., Ltd., 2008-2010 
Sales Revenue of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., 2007
International Sales Network of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., 2007
The Highest Retail Price of Partial Blood Products according to National Development and Reform Commission. 

China Animal Vaccine Industry Report, 2019-2025

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized ba...

China Blood Product Industry Report, 2020-2026

With the dynamic adjustment in the catalog of medicines covered by national medical insurance system, the scope of clinical use of almost all blood products grows tremendously, so does the reimburseme...

China Vacuum Blood Collection Device Industry Report, 2019-2025

As laboratory medicine advances, favorable polices are issued and people live a better life and care more about their health, vacuum blood collection systems get increasingly used. In 2018, global vac...

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号